Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria

BACKGROUND: This analysis evaluates the cost-effectiveness of insulin degludec (degludec) versus biosimilar insulin glargine U100 (glargine U100) in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) in Bulgaria. METHODS: A simple, short-term model was used to compare the treatment cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Russel-Szymczyk, Monika, Valov, Vasil, Savova, Alexandra, Manova, Manoela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891960/
https://www.ncbi.nlm.nih.gov/pubmed/31796048
http://dx.doi.org/10.1186/s12902-019-0460-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891960/
https://www.ncbi.nlm.nih.gov/pubmed/31796048
http://dx.doi.org/10.1186/s12902-019-0460-6

Ejemplares similares